Features April 2007 Issue

TNF Inhibitors: When Traditional RA-Fighters Aren’t Enough

New drugs to manage rheumatoid arthritis have become easier to use—and there are more promising developments in the pipeline.

Slowing joint destruction is the goal of nearly all rheumatoid arthritis (RA) drugs. And doctors are getting more aggressive about using these drugs earlier in the disease process in order to halt such changes before they become permanent or irreversible.

To continue reading this article you must be a paid subscriber.

Subscribe to Arthritis Advisor

Arthritis Advisor is the first magazine published by one one of the world's leading orthopaedic hospitals specifically for people with arthritis.

Subscriber Log In

Forgot your password? Click Here.

Already subscribe but haven't registered for all the benefits of the website? Click here.